---
title: "LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-Driven Antibody Optimisation Programs"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/268563449.md"
description: "LabGenius Therapeutics announced a second collaboration with Sanofi. This collaboration combines LabGenius' AI/ML-driven antibody design capabilities with Sanofi's expertise in the development of therapeutic NANOBODY molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA platform to optimise NANOBODY molecules for multiple new targets in the area of inflammation."
datetime: "2025-12-04T09:10:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268563449.md)
  - [en](https://longbridge.com/en/news/268563449.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268563449.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/268563449.md) | [繁體中文](https://longbridge.com/zh-HK/news/268563449.md)


# LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-Driven Antibody Optimisation Programs

LabGenius Therapeutics announced a second collaboration with Sanofi. This collaboration combines LabGenius' AI/ML-driven antibody design capabilities with Sanofi's expertise in the development of therapeutic NANOBODY molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA platform to optimise NANOBODY molecules for multiple new targets in the area of inflammation.

### 相关股票

- [Sanofi (SNYNF.US)](https://longbridge.com/zh-CN/quote/SNYNF.US.md)

## 相关资讯与研究

- [Sanofi’s Sarclisa Subcutaneous Formulation Via On-Body Injector Recommended For EU Approval](https://longbridge.com/zh-CN/news/280786871.md)
- [Sanofi Secures EU Conditional Marketing Approval for Graft-vs-Host Disease Medicine](https://longbridge.com/zh-CN/news/281129645.md)
- [Insig AI Plans Growth Drive and Eyes Nasdaq Dual Listing](https://longbridge.com/zh-CN/news/281311983.md)
- [Lattice Acquires Mandala Technology, Advancing the New Way to Work with People + AI](https://longbridge.com/zh-CN/news/281231794.md)
- [Fusemachines Expands Distribution of Its AI Agents Through Global Teams AI Reseller Agreement, Launching with Interview AI Agent | FUSE Stock News](https://longbridge.com/zh-CN/news/281184677.md)